The role of cancer research in noncommunicable disease control

Journal of the National Cancer Institute

Volumn 104, Issue 14, 2012, Pages 1051-1058

  Wild, Christopher Paul ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; WART VIRUS VACCINE;

ALCOHOL CONSUMPTION; AWARENESS; BREAST CANCER; CANCER CONTROL; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PREVENTION; CANCER RESEARCH; CANCER RISK; CANCER SCREENING; CARDIOVASCULAR DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; COLORECTAL CANCER; DIABETES MELLITUS; DISEASE CONTROL; EARLY DIAGNOSIS; ESOPHAGUS CANCER; FASCIOLA HEPATICA; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HIGH RISK POPULATION; HUMAN; HUMAN HERPESVIRUS 8; HYPERTENSION; IMMOBILIZATION; LIFESTYLE; LIVER CANCER; LOWEST INCOME GROUP; LUNG CANCER; MELANOMA; MORBIDITY; NEOPLASM; NONHODGKIN LYMPHOMA; OBESITY; ORGANIZATION; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RISK FACTOR; TOBACCO; UTERINE CERVIX CANCER; VACCINATION; VIRUS INFECTION; WART VIRUS;

BIOMEDICAL RESEARCH; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; CONGRESSES AS TOPIC; COST OF ILLNESS; DIABETES MELLITUS; EARLY DETECTION OF CANCER; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INCIDENCE; LIFE STYLE; NEOPLASMS; POLITICS; PRIMARY PREVENTION; RESPIRATORY TRACT DISEASES; RISK FACTORS; UNITED NATIONS; WORLD HEALTH;

EID: 84864453801     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djs262     Document Type: Review

References (28)

1. Political declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases, United Nations, (2011). http://www.un.org/ga/search/view-doc.asp?symbol=A/66/L.1. Accessed October 20, 2011.
2. World Health Organization (WHO). Global Strategy for the Prevention and Control of Noncommunicable Diseases: Report by the Director-General. Geneva, Switzerland: WHO; 1999. Endorsed by Resolution WHA 53/14 (March 2000). http://apps.who.int/gb/archive/pdf-files/WHA53/ea14. pdf. Accessed October 20, 2011.
3. World Health Organization (WHO). Global Strategy to Reduce the Harmful Use of Alcohol. Geneva, Switzerland: WHO; 2010. Endorsed by Resolution WHA 63/13 (May 2010). http://www.who.int/substance-abuse/alcstratenglishfinal.pdf. Accessed October 20, 2011.
4. World Health Organization (WHO). Global Strategy on Diet, Physical Activity and Health. Geneva, Switzerland: WHO; 2004. Endorsed by Resolution WHA 57/17 (May 2004). http://www.who.int/dietphysicalactivity/strategy/eb11344/ strategy-english-web.pdf. Accessed October 20, 2011.
5. Beaglehole R, Bonita R, Horton R, et al. Priority actions for the non-communicable disease crisis. Lancet. 2011;377(9775):1438-1447.
6. Beaglehole R, Bonita R, Alleyne G, et al. UN High-Level Meeting on Non-Communicable Diseases: Addressing four questions. Lancet. 2011;378(9789):449-455.
7. World Health Organization (WHO). Global Status Report on Noncommunicable Diseases 2010-Description of the Global Burden of NCDs, Their Risk Factors and Determinants. Geneva, Switzerland: WHO. 2011. http://whqlibdoc.who.int/ publications/2011/9789240686458-eng.pdf. Accessed October 20, 2011.
8. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide. Lyon, France: International Agency for Research on Cancer; 2010. IARC Cancer Base No. 10. http://globocan.iarc.fr. Accessed October 20, 2011.
9. Cogliano VJ, Baan R, Straif K, et al. Preventable exposures associated with human cancers. J Natl Cancer Inst. 2011;103:1827-1839.
10. World Cancer Research Fund/American Institute for Cancer Research (AICR). Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC. AICR; 2007.
11. de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: A review and synthetic analysis. The Lancet Oncology. 2012;13:607-615.
12. Wild CP. Future research perspectives on environment and health: The requirement for a more expansive concept of translational cancer research. Environ Health. 2011;10(suppl 1):S15.
13. Sankaranarayanan R, Swaminathan R, Brenner H, et al. Cancer survival in Africa, Asia, and Central America: A population-based study. Lancet Oncol. 2010;11(2):165-173.
14. Farmer P, Frenk J, Knaul FM, et al. Expansion of cancer care and control in countries of low and middle income: A call to action. Lancet. 2010;376(9747):1186-1193.
15. Sankaranarayanan R, Ramadas K, Thara S, et al. Clinical breast examination: Preliminary results from a cluster randomized controlled trial in India. J Natl Cancer Inst. 2011;103(19):1476-1480.
16. Kreimer AR, Rodriguez AC, Hildesheim A, et al. Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine. J Natl Cancer Inst. 2011;103(19):1444-1451.
17. Franceschi S, Denny L, Irwin KL, et al. Eurogin 2010 roadmap on cervical cancer prevention. Int J Cancer. 2011;128(12):2765-2774.
18. Harford JB. Breast-cancer early detection in low-income and middleincome countries: Do what you can versus one size fits all. Lancet Oncol. 2011;12(3):306-312.
19. Institute of Medicine of the National Academies Committee on Cancer Control in Low- and Middle-Income Countries. Cancer Control Opportunities in Low- and Middle-Income Countries. Washington, DC. The National Academies Press. 2007.
20. Knaul FM, Frenk J, Shulman L for the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries. Closing the Cancer Divide: A Blueprint to Expand Access in Low and Middle Income Countries. Boston, MA: Harvard Global Equity Initiative; 2011.
21. Union for International Cancer Control. World Cancer Declaration. http://www.uicc.org/declaration. Accessed June 19, 2012.
22. International Agency for Research on Cancer. Global Initiative for Cancer Registry Development in Low- and Middle-Income Countries. http://gicr. iarc.fr/. Accessed June 19, 2012.
23. Wild CP. How much of a contribution do exposures experienced between conception and adolescence make to the burden of cancer in adults? Cancer Epidemiol Biomarkers Prev. 2011;20(4):580-581.
24. Wild CP. Complementing the genome with an "exposome": The outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev. 2005;14(8):1847-1850.
25. Rappaport SM, Smith MT. Epidemiology. Environment and disease risks. Science. 2010;330(6003):460-461.
26. Wild CP, Gong YY. Mycotoxins and human disease: A largely ignored global health issue. Carcinogenesis. 2010;31(1):71-82.
27. Goldie SJ, Daniels N. Model-based analyses to compare health and economic outcomes of cancer control: Inclusion of disparities. J Natl Cancer Inst. 2011;103(18):1373-1386.
28. Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008-2030): A populationbased study. The Lancet Oncology. Forthcoming.